Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-7: Ticagrelor vs Prasugrel Monotherapy
NCT06691191Phase 4Recruiting
- Sponsor
- University of Florida
- Start
- Jan 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel, ticagrelor in coronary artery disease (CAD), sponsored by University of Florida. Started Jan 2025; status: recruiting.
02
Drugs
prasugrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06691191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06691191.